Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of targeted therapies for women's cancers. Its lead product candidate, OP-1250, is an oral therapy w... Read more
SeekingAlpha
SeekingAlpha
SeekingAlpha
SeekingAlpha
Access detailed stock analysis from LSEG including analyst price target estimates.